Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
about
Protecting against plague: towards a next-generation vaccinePlague Vaccine Development: Current Research and Future TrendsThe Baboon (Papio spp.) as a model of human Ebola virus infection.Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Evaluation of immunogenicity and protective efficacy of recombinant outer membrane proteins of Haemophilus parasuis serovar 5 in a murine model.Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule.HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Prophylaxis and therapy of plague.Plague vaccines: current developments and future perspectives.The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques.
P2860
Q26823422-577F28D3-0082-403C-943D-30F2959B0109Q28066875-58E2AF86-C252-4F60-B92B-F34F070EE7AAQ33404644-D342BFEE-0B26-46B6-B65F-4E3D212AD3EEQ33603015-6E0D1574-42ED-4E90-A100-2227187CDBEFQ33611003-28FFE27C-BB5C-4C89-918F-B450CAA88C09Q33786763-D2452E5D-0B61-4E87-8B02-B6AD002F83A2Q34159659-D19B01CE-F4FB-4B85-A736-D3AD74E8962EQ34633478-B1461BCD-96DF-4E3E-8F12-2F0B51E83D2CQ35186608-877AC6F6-9852-4413-B431-5F0226B6F9B3Q35439470-0C53F8DF-7DBB-4BB1-BD6B-785E1B49CD95Q36316792-7B667B29-4A69-4DF1-A4DD-5B350326E104Q36368527-D15A310A-0632-4DA0-BCCB-6EFC37D556C0Q36513899-C10B61CC-02ED-4A62-9555-30C7B7F6162FQ36606805-0A06EBBE-ADB6-42AA-83EE-FC3AA49E3ECFQ36911486-37EBFB73-6619-4D22-9A9E-7D151B44FBF5Q37067254-DE11EE28-3E1F-4267-939C-E8A6CF7F34B4Q38131537-CCD5B3D7-CC7B-4BCA-822B-57D1090DA70DQ38514208-4484C0DE-1965-46F3-A101-C0EE538A203FQ38589273-436BE6D9-67F6-45A2-AE58-D1E55D7ED9FFQ41400297-C811A7ED-DEE1-499C-8040-18183FD28224Q46463260-0EDFB8A9-A65D-4E26-9B9D-CDDB4F812FF5Q47293934-70B3EBD7-A02C-49B2-9A52-DBED9304D623Q48309869-4D789AA1-1472-4002-9954-698A7B81393A
P2860
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
@en
type
label
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
@en
prefLabel
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
@en
P2093
P1433
P1476
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague
@en
P2093
E D Williamson
E L Waters
J Hartings
N Twenhafel
P J Packer
P304
P356
10.1016/J.VACCINE.2011.04.084
P407
P577
2011-05-12T00:00:00Z